Use Iris to turn launch complexity into commercial momentum.
Iris works like a cross-functional commercial expert, trained on launch patterns, in-market performance, and the actions required to improve uptake.

The industry is shifting.
Specialty launch teams need a faster way to interpret change and move in sync.
6–12 months
Post-approval coverage gap. Where launch trajectory is now set.
ICER, 2025
55%
HCPs with restricted or no rep access. Engagement now extends beyond the rep.
Veeva Pulse Field Trends Report, 2024
$263Bn
U.S. specialty medicine spending in 2024 — now 54% of total spend. Structural shift, not a cycle.
IQVIA Institute, 2025
Interpretation gets harder under complexity.
Each function sees a different part of the launch.
Iris gives teams a shared view of what changed, why it matters, and what to do next.
Review, question, and steer — don't stitch.
AI that doesn't just answer.
Most AI helps teams respond faster. The next evolution helps experts question, reason, and decide differently.
Iris is the first commercial reasoning OS purpose-built for pharma.
- Iris collaborates — you stay at the helm.
- It surfaces signals, interprets them, and drafts what's needed. You question it, adjust the assumptions and finalize the work together. Iris delivers it into the flow of work or leaves it to you to take the action.
- The result: faster responses, coordinated action across teams, and forecasts your teams can defend
Continuous detection
Iris monitors formulary shifts, payer policy updates, adjudication patterns, and competitive moves — surfacing what matters inside the window where you can still act.
Reasoning, not retrieval
Iris explains what each signal means, why it matters, and how urgent it is. Every answer and recommendation is traceable — not a black box. Built on purpose-built small language models, not generic AI agents.
Improve uptake and pull-through with Iris as your co-expert.
Every commercial team gets Iris, specific to their role — so they can move faster and within their objectives and guardrails.
How Iris works with you
Interprets payer changes, drafts access strategy, and surfaces where coverage or pull-through is breaking.
What's coming is more pressure, not less.
Tighter access, faster competition, narrower launch windows, and higher expectations on commercial execution.
The alternative is more capable tools layered onto the same fragmented operating model — still leaving commercial teams to piece together the market one function at a time.
Put Iris to work today
See how Iris detects, interprets, and reasons across your commercial landscape — in real-time. Book a demo and we'll show you what's possible.